Peony seed oil protects against obesity-induced non-alcoholic fatty liver disease via modulation of endoplasmic reticulum stress
Abstract
Purpose: To investigate the effect of Peony seed oil (PO) on non-alcoholic fatty liver disease (NAFLD), and the underlying mechanism of action.
Methods: A mouse model of NAFLD was established using high-fat diet (HFD) for 12 weeks. Serum levels of triacylglycerol (TG), total cholesterol (TC), glucose and free fatty acids (FFAs) were determined. Activities of aspartate aminotransferase (AST) and alanine amino transferase (ALT) were assayed in liver homogenates, while mRNA and protein expressions of GRP78, x-box binding protein 1 (XBP1) and phosphorylated inositol-requiring enzyme 1 (p-IRE1α) were assayed in liver tissue using real-time quantitative polymerase chain reaction (qRT-PCR) and Western blotting, respectively. Expression levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-1β (IL-1β) were also determined by qRT-PCR.
Results: HFD diet led to significant increases in body weight as well as serum TG, TC, glucose and FFA levels. However, treatment with PO significantly reversed the effect of HFD on these parameters (p < 0.05). The mRNA expression levels of TNF- α, IL-6 and IL-1β were significantly higher in HFD control group than in normal control group, but were significantly reduced after PO treatment (p < 0.05). The protein expression levels of GRP78, XBP-1 and p-IRE1α significantly increased in the liver of NAFLD group, when compared with normal control rats, but were significantly downregulated by treatment with PO (p < 0.05).
Conclusion: PO attenuates HFD-induced NAFLD via inactivation of endoplasmic reticulum stress (ERS) pathway. Thus, PO has potentials for the treatment of NAFLD but further studies are required to ascertain this.
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
